Topics

Latest "Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines" News Stories

06:26 EST 24th February 2020 | BioPortfolio

Here are the most relevant search results for "Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines" found in our extensive news archives from over 250 global news sources.

More Information about Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines for you to read. Along with our medical data and news we also list Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines Clinical Trials, which are updated daily. BioPortfolio also has a large database of Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines Companies for you to search.

Showing "Catalyzed Selective Allylation Hydroamination Cascade Synthesis Dihydroisoquinolines" News Articles 1–25 of 1,400+

Monday 24th February 2020

Dipharma Francis S.r.l. completes construction of new cGMP Suite in USA

Located in Kalamazoo (MI), the New GMP-compliant Kilolab and QC Laboratory will manage supply for clinical Phase 1 and early Phase 2 Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical Ingredients, announces today the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at i...


Clover and GSK Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with Pandemic Adjuvant System

Clover Biopharmaceuticals, a China based global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced today that it has entered into a research collaboration with GSK for its protein-based coronavirus vaccine candidate (COVID-19 S-Trimer). GSK will provide Clover with its pandemic adjuvant system for further evaluation of S-Trimer in pre...

Saturday 22nd February 2020

20172025 World Thymidine Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummaryThymidine deoxythymidine; other names deoxyribosylthymine, thymine deoxyriboside is a pyrimidine deoxynucleoside. It is a pharmaceutical intermediate that used to make antiAIDS drugs aidovudine.This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end indu...


Shying Away From The Spotlight - New Study Hints at Why Some People Can’t Accept Compliments

While modesty may play a role, a recent study by Queendom.com reveals that a tendency to shirk praise is associated with low self-esteem, pessimism, and a general dissatisfaction with life. MONTREAL (PRWEB) February 22, 2020 Although many people thrive on praise, not everyone welcomes it. Modesty aside, a study conducted by Queendom.com reveals that some people who dismiss compliments struggle wi...

Friday 21st February 2020

Series C round brings in $45M for NeoTX

NeoTX Therapeutics Ltd. (targeted cancer treatments) raised $45M from undisclosed investors in its Series C round. The compan...

Polarized Sunglasses Market 2019-2023 | Rising Product Premiumization Due to Increased Innovation and Portfolio Extension to Boost Growth | Technavio

Technavio has been monitoring the polarized sunglasses market and it is poised to grow by USD 1.77 billion during 2019-2023, progressing at a CAGR of 7% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https:/...

Thursday 20th February 2020

Dicerna™ to Report Fourth Quarter and Full Year 2019 Financial Results on Feb. 27, 2020

Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its fourth quarter and full year 2019 financial results after market close on Thursday, Feb. 27, 2020. Management will host a conference call at 4:30 p.m. ET that day to discuss the Company's financial results an...

Galapagos NV: Transformational year for Galapagos

Strong balance sheet for continued growth Key 2019 events: Unique R&D agreement signed with collaboration partner GileadApplications for approval of selective JAK1 inhibitor filgotinib in rheumato...

20172025 World SCR Denitrification Catalyst Market Research Report by Product Type, EndUser / Application and Regions / Countries [Published by HeyReport] Prices from USD $2380

SummarySCR Denitrification Catalyst is selective catalyst in denitrification system, to catalytically reduce NOx mainly NO and NO2 to N2 in presence of reduced agents, such as NH3. SCR is today the dominant technology for the control of NOx in power industry, steel industry, cement industry, glass industry, metallurgy industry, etc. In the report, cbm is equivalent tocubic meter.This report includ...

Autism Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $1700

Autism Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Autism Pipeline Review, H2 2019, provides an overview of the Autism Central Nervous System pipeline landscape.Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and rep...

FORMA Therapeutics Announces FT-4202 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Sickle Cell Disease

FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation and Rare Pediatric Disease designation for its lead clinical asset, FT-4202, in development as a disease-

Calidi Biotherapeutics Announces Appointment of Biotech Veteran Heehyoung Lee to Board of Directors

Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive, Heehyoung Lee, Managing Partner at LumeBio, to its b

Wednesday 19th February 2020

Spruce Biosciences Raises $88 Million in Series B Financing, co-led by Omega Funds and Abingworth

- Proceeds to advance development of Tildacerfont in Congenital Adrenal Hyperplasia and other indications - Existing Investors Novo Holdings and RiverVest Venture Partners support the deal with new Investors HealthCap Partners, Rock Springs Capital, Aisling Capital, Surveyor Capital (a Citadel company) and Sands Capital joining the syndicate Spruce Biosciences today announced it has raised $8...

Selective loading and processing of prespacers for precise CRISPR adaptation

Anti-Fibrotic Activity of Hepion Pharmaceuticals’ CRV431 Shows Potential to Extend to Multiple Organs and Fibrotic Diseases

CRV431 Decreases Collagen and Fibronectin Production from Multiple Cell Types EDISON, NJ / ACCESSWIRE / February 19, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced results from in vitro studies showing tha...

Growth factor-modified stem cells help repair spinal cord injuries in rats

A new study released today in STEM CELLS Translational Medicine is the first to illustrate the presence of oxygen-deprived clusters throughout the damaged site of a compressed spinal cord. DURHAM, N.C. (PRWEB) February 19, 2020 A new study released today in STEM CELLS Translational Medicine is the first to illustrate the presence of oxygen-deprived clusters throughout the damaged site of a compre...

Alzheimer's Disease Pipeline Review, H2 2019 [Published by Global Markets Direct] Prices from USD $2125

Alzheimer's Disease Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease Pipeline Review, H2 2019, provides an overview of the Alzheimer's Disease Central Nervous System pipeline landscape.Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the...

Israeli co NeoTX Therapeutics raises $45m

The Rehovot-based company is leveraging its proprietary Selective T cell Redirection (STR) platform to develop targeted anticancer immunotherapies.

ESCAPE Bio to Present at the 9th Annual SVB Leerink Global Healthcare Conference

ESCAPE Bio, Inc., a clinical stage company developing novel, precisely targeted therapeutics for genetically defined neurodegenerative diseases, today announced that Julie Anne Smith, Chief Executive Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020. Presentation details Date: Tuesday, February 25, 2020 Time: 2:00 p.m. ET Location: Lo...

Peptide Therapeutics Market 2019-2023 | Growing Cases of Chronic Diseases to Boost Growth | Technavio

Technavio has been monitoring the peptide therapeutics market and it is poised to grow by USD 16 billion during 2019-2023, progressing at a CAGR of 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://w...

Nutraceuticals Market 2019-2023 | Rising Demand for Nutraceuticals with Medical Benefits to Boost Growth | Technavio

Technavio has been monitoring the nutraceuticals market and it is poised to grow by USD 149.89 billion during 2019-2023, progressing at a CAGR of 8% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www...

Terns Pharmaceuticals Announces Safety and Pharmacodynamic Results of a Phase 1 Clinical Trial of TERN-101, a Liver-Selective FXR Agonist in Development for the Treatment of NASH

-Phase 1 study demonstrated TERN-101 is safe and exhibits potent target engagement at all dose levels studied- -Phase 2 studies of TERN-101 expected to begin in NASH patients in mid-2020- Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced the complet...

Global Chymotrypsin Market Research 20152019 and Future Forecast 20202025 [Published by 99Strategy] Prices from USD $2805

SummaryThe report forecast global Chymotrypsin market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 20202025.The report offers detailed coverage of Chymotrypsin industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Chymotrypsin by geography. The...

Tuesday 18th February 2020

Global Naphthalene Market Research 20152019 and Future Forecast 20202025 [Published by 99Strategy] Prices from USD $2805

SummaryThe report forecast global Naphthalene market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 20202025.The report offers detailed coverage of Naphthalene industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Naphthalene by geography. The re...

Keeping it simple -- Synthesizing useful organic compounds now made easier and cheaper

(Tokyo University of Science) Organic boronic acids are widely used as starting material in the synthesis of various useful chemicals. But, some organic boronic acids are unstable and lead to unwanted 'side reactions.' Thus, they need to be protected with a functional group, which needs to be removed afterwards. A research team from Tokyo University of Science recently uncovered how this unnecessa...


Quick Search

News Quicklinks